190 related articles for article (PubMed ID: 34441839)
1. Detailed Phenotype of GLA Variants Identified by the Nationwide Neurological Screening of Stroke Patients in the Czech Republic.
Reková P; Dostálová G; Kemlink D; Paulasová Schwabová J; Dubská Z; Vaneckova M; Mašek M; Kodet O; Poupětová H; Mazurová S; Rajdova A; Vlckova E; Táboříková A; Fafejtová Š; Nevsimalova M; Linhart A; Tomek A
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441839
[TBL] [Abstract][Full Text] [Related]
2. Nationwide screening for Fabry disease in unselected stroke patients.
Tomek A; Petra R; Paulasová Schwabová J; Olšerová A; Škorňa M; Nevšímalová M; Šimůnek L; Herzig R; Fafejtová Š; Mikulenka P; Táboříková A; Neumann J; Brzezny R; Sobolová H; Bartoník J; Václavík D; Vachová M; Bechyně K; Havlíková H; Prax T; Šaňák D; Černíková I; Ondečková I; Procházka P; Rajner J; Škoda M; Novák J; Škoda O; Bar M; Mikulík R; Dostálová G; Linhart A;
PLoS One; 2021; 16(12):e0260601. PubMed ID: 34905550
[TBL] [Abstract][Full Text] [Related]
3. Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young.
De Brabander I; Yperzeele L; Ceuterick-De Groote C; Brouns R; Baker R; Belachew S; Delbecq J; De Keulenaer G; Dethy S; Eyskens F; Fumal A; Hemelsoet D; Hughes D; Jeangette S; Nuytten D; Redondo P; Sadzot B; Sindic C; Sheorajpanday R; Thijs V; Van Broeckhoven C; De Deyn PP
Clin Neurol Neurosurg; 2013 Jul; 115(7):1088-93. PubMed ID: 23219219
[TBL] [Abstract][Full Text] [Related]
4. Fabry disease screening in high-risk populations in Japan: a nationwide study.
Yoshida S; Kido J; Sawada T; Momosaki K; Sugawara K; Matsumoto S; Endo F; Nakamura K
Orphanet J Rare Dis; 2020 Aug; 15(1):220. PubMed ID: 32843101
[TBL] [Abstract][Full Text] [Related]
5. Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients.
Rosa Neto NS; Bento JCB; Pereira RMR
Adv Rheumatol; 2020 Jan; 60(1):7. PubMed ID: 31907047
[TBL] [Abstract][Full Text] [Related]
6. Identifying Fabry patients in dialysis population: prevalence of GLA mutations by renal clinic screening, 1995-2019.
Capuano I; Garofalo C; Buonanno P; Pinelli M; Di Risi T; Feriozzi S; Riccio E; Pisani A
J Nephrol; 2020 Jun; 33(3):569-581. PubMed ID: 31650418
[TBL] [Abstract][Full Text] [Related]
7. Late onset variants in Fabry disease: Results in high risk population screenings in Argentina.
Serebrinsky G; Calvo M; Fernandez S; Saito S; Ohno K; Wallace E; Warnock D; Sakuraba H; Politei J
Mol Genet Metab Rep; 2015 Sep; 4():19-24. PubMed ID: 26937405
[TBL] [Abstract][Full Text] [Related]
8. Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease.
Germain DP; Levade T; Hachulla E; Knebelmann B; Lacombe D; Seguin VL; Nguyen K; Noël E; Rabès JP
Clin Genet; 2022 Apr; 101(4):390-402. PubMed ID: 34927718
[TBL] [Abstract][Full Text] [Related]
9. The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants.
Sánchez R; Ripoll-Vera T; López-Mendoza M; de Juan-Ribera J; Gimeno JR; Hermida Á; Ruz-Zafra MA; Torregrosa JV; Mora A; García-Pinilla JM; Fortuny E; Aguinaga-Barrilero A; Torra R
Orphanet J Rare Dis; 2023 Jan; 18(1):8. PubMed ID: 36624527
[TBL] [Abstract][Full Text] [Related]
10. Fabry disease caused by the GLA p.Phe113Leu (p.F113L) variant: Natural history in males.
Oliveira JP; Nowak A; Barbey F; Torres M; Nunes JP; Teixeira-E-Costa F; Carvalho F; Sampaio S; Tavares I; Pereira O; Soares AL; Carmona C; Cardoso MT; Jurca-Simina IE; Spada M; Ferreira S; Germain DP
Eur J Med Genet; 2020 Feb; 63(2):103703. PubMed ID: 31200018
[TBL] [Abstract][Full Text] [Related]
11. Fabry Disease: prevalence of affected males and heterozygotes with pathogenic
Doheny D; Srinivasan R; Pagant S; Chen B; Yasuda M; Desnick RJ
J Med Genet; 2018 Apr; 55(4):261-268. PubMed ID: 29330335
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of unknown significance in alpha-galactosidase A: Cellular delineation from Fabry disease.
Klein A; Klug K; Breyer M; Grüner J; Medala VK; Nordbeck P; Wanner C; Klopocki E; Üçeyler N
J Inherit Metab Dis; 2024 Apr; ():. PubMed ID: 38618884
[TBL] [Abstract][Full Text] [Related]
13. A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance.
van der Tol L; Smid BE; Poorthuis BJ; Biegstraaten M; Deprez RH; Linthorst GE; Hollak CE
J Med Genet; 2014 Jan; 51(1):1-9. PubMed ID: 23922385
[TBL] [Abstract][Full Text] [Related]
14. The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies.
Ferreira S; Ortiz A; Germain DP; Viana-Baptista M; Caldeira-Gomes A; Camprecios M; Fenollar-Cortés M; Gallegos-Villalobos Á; Garcia D; García-Robles JA; Egido J; Gutiérrez-Rivas E; Herrero JA; Mas S; Oancea R; Péres P; Salazar-Martín LM; Solera-Garcia J; Alves H; Garman SC; Oliveira JP
Mol Genet Metab; 2015 Feb; 114(2):248-58. PubMed ID: 25468652
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
Duro G; Zizzo C; Cammarata G; Burlina A; Burlina A; Polo G; Scalia S; Oliveri R; Sciarrino S; Francofonte D; Alessandro R; Pisani A; Palladino G; Napoletano R; Tenuta M; Masarone D; Limongelli G; Riccio E; Frustaci A; Chimenti C; Ferri C; Pieruzzi F; Pieroni M; Spada M; Castana C; Caserta M; Monte I; Rodolico MS; Feriozzi S; Battaglia Y; Amico L; Losi MA; Autore C; Lombardi M; Zoccali C; Testa A; Postorino M; Mignani R; Zachara E; Giordano A; Colomba P
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477121
[TBL] [Abstract][Full Text] [Related]
16. First phenotypic description of a female patient with c.610 T > C variant of GLA: a renal-predominant presentation of Fabry disease.
Greillier S; Daniel L; Caillaud C; Dussol B; Touchard G; Goujon JM; Jourde-Chiche N; Bobot M
BMC Med Genet; 2020 Jun; 21(1):137. PubMed ID: 32590976
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey: Underdiagnosis of late-onset phenotype.
Choi JH; Lee BH; Heo SH; Kim GH; Kim YM; Kim DS; Ko JM; Sohn YB; Hong YH; Lee DH; Kook H; Lim HH; Kim KH; Kim WS; Hong GR; Kim SH; Park SH; Kim CD; Kim SM; Seo JS; Yoo HW
Medicine (Baltimore); 2017 Jul; 96(29):e7387. PubMed ID: 28723748
[TBL] [Abstract][Full Text] [Related]
18. Questioning the Pathogenic Role of the GLA p.Ala143Thr "Mutation" in Fabry Disease: Implications for Screening Studies and ERT.
Terryn W; Vanholder R; Hemelsoet D; Leroy BP; Van Biesen W; De Schoenmakere G; Wuyts B; Claes K; De Backer J; De Paepe G; Fogo A; Praet M; Poppe B
JIMD Rep; 2013; 8():101-8. PubMed ID: 23430526
[TBL] [Abstract][Full Text] [Related]
19. Correlation between GLA variants and alpha-Galactosidase A profile in dried blood spot: an observational study in Brazilian patients.
Varela P; Mastroianni Kirsztajn G; Motta FL; Martin RP; Turaça LT; Ferrer HLF; Gomes CP; Nicolicht P; Mara Marins M; Pessoa JG; Braga MC; D'Almeida V; Martins AM; Pesquero JB
Orphanet J Rare Dis; 2020 Jan; 15(1):30. PubMed ID: 31996269
[TBL] [Abstract][Full Text] [Related]
20. Use of a rare disease registry for establishing phenotypic classification of previously unassigned
Germain DP; Oliveira JP; Bichet DG; Yoo HW; Hopkin RJ; Lemay R; Politei J; Wanner C; Wilcox WR; Warnock DG
J Med Genet; 2020 Aug; 57(8):542-551. PubMed ID: 32161151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
